YIELD GROWTH Announces New Product, Urban Juve Micellar Water, in Final Stage of Testing
VANCOUVER, British Columbia, March 28, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (Frankfurt:YG3) is pleased to announce that it has completed product development of Urban Juve Micellar Water, a new, gentle facial cleanser, which is in the final testing phase before launch. Traditional soap cleansers work by creating... Read more
International Cannabis Announces Inclusion to the Horizons HMMJ ETF
Ryan Allway March 25th, 2019 News, Top News VANCOUVER, British Columbia, March 25, 2019 (GLOBE NEWSWIRE) — ICC International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) (“ICC” or “International Cannabis” or the “Company”) is pleased to announce its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (the... Read more
Supreme Cannabis Launching Cannabis Oil Products in the Canadian Consumer Market
Proprietary oil formulation expected to be introduced in April 2019 for select markets with roll out to additional provinces expected by the end of June 2019. The oil products will be produced using High-End CannabisTM grown by 7ACRES and formulated to preserve the naturally occurring terpenes unique to the strain. TORONTO, March 22, 2019 /PRNewswire/... Read more
Next Green Wave’s Nursery Botticelli(TM) Research & Development Program Begins
Vancouver, British Columbia–(Newsfile Corp. – March 22, 2019) – Next Green Wave Holdings Inc. (CSE: NGW) (OTCQB: NXGWF) (“Next Green Wave“, “NGW” or the “Company”), is pleased to announce that is has begun the optimization phase of the strategic licensing agreement with Intrexon Corporation (NASDAQ: XON) (“Intrexon”) to utilize Intrexon’s Botticelli™ next generation plant propagation platform to... Read more
Yield Growth Achieves Revenue of $3.1 Million for Its Fiscal Year Ended November 30, 2018
VANCOUVER, British Columbia, March 22, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) (Frankfurt: YG3) on a consolidated basis (the “Company”) has released its financial and operational results for the year ended November 30, 2018.  These filings are available for review on the Company’s SEDAR profile at www.sedar.com. UPDATE ON... Read more
Westleaf Added to World’s First and Largest Cannabis ETF
Westleaf joins leading cannabis companies on Horizons Marijuana Life Sciences Index ETF CALGARY, March 22, 2019 /PRNewswire/ – Westleaf Inc. (TSX-V: WL) (OTCQB:WSLFF) (“Westleaf“), is pleased to announce it has been included on the Horizons Marijuana Life Sciences ETF (“HMMJ“) (“TSX:HMMJ”). HMMJ is an index (or passively managed) ETF, which seeks to replicate,... Read more
The Science Behind Medical Marijuana is Flawed
Robin Lefferts March 21st, 2019 Exclusive, News, Top News To hear some advocates talk about it, cannabis is a miracle drug, capable of treating everything from chronic pain, nausea, chemotherapy side effects, muscle spasms, multiple sclerosis, and more. And it’s true. Medical marijuana and cannabidiol (CBD) have been used... Read more
BLOCKStrain: Three Target Markets, One Breakthrough Platform
Ryan Allway March 19th, 2019 Exclusive, News, Top News The global cannabis industry is projected to reach nearly $150 billion by 2025, according to Grand View Research, as a growing number of governments legalize marijuana. While legalization has created an overnight multi-billion dollar market for investors, consumers, cultivators, and... Read more
Westleaf Submits Extracts and Edibles Comments to Health Canada Ahead of Legalization
Ryan Allway March 19th, 2019 News, Top News Recently, Health Canada released draft regulations for the next major phase of cannabis legalization in Canada. Part of that disclosure was an invitation to all parties to submit suggestions and recommendations about improving the regulations and prepare the environment for the... Read more
Pascal Biosciences Partners with Mitacs to Support Innovative Cancer Research at University of British Columbia
VANCOUVER, British Columbia and SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced a partnership with Mitacs for a multi-year cancer research project at the University of British Columbia (UBC).  Mitacs, a not-for-profit organization that... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )